The Intranasal Administration of Transferrin‐Loaded Extracellular Vesicles Enhances Remyelination

Autores
Mattera, Vanesa Soledad
Año de publicación
2025
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Oligodendrocytes (OLs), the myelinating glial cells of the central nervous system (CNS), are impaired in demyelinating diseases such as multiple sclerosis (MS). OL loss is characterized by inflammation, immune cell activity, and a failure of remyelination due to oligodendrocyte dysfunction and death, ultimately leading to demyelination and axonal damage. Given their central role in maintaining CNS integrity, therapeutic strategies aimed at protecting or restoring OL function are essential. Moreover, the limited permeability of the blood–brain barrier to many therapeutic compounds remains a major challenge, highlighting the need for innovative delivery approaches. Among these, the intranasal (IN) route has emerged as a promising noninvasive strategy for targeting the CNS. Within this therapeutic framework, Transferrin (Tf), a glycoprotein involved in iron homeostasis, has been shown to promote both developmental myelination and remyelination by redistributing and delivering iron, an essential cofactor for OL maturation and oxidative metabolism. In parallel, extracellular vesicles (EVs) have gained increasing attention as mediators of intercellular communication and potential drug delivery vehicles to the brain, offering advantages such as minimal immunogenicity, efficient cellular uptake, and cargo protection from degradation. In this review, the potential of EVs as biological carriers of molecules to promote remyelination is discussed, with a particular focus on Tf delivered via the intranasal route, as well as the cellular mechanisms underlying this internalization.
Fil: Mattera, Vanesa Soledad. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Química y Físico-Química Biológicas "Prof. Alejandro C. Paladini". Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Instituto de Química y Físico-Química Biológicas; Argentina
Materia
OLIGODENDROCYTES
MYELINATION
EXTRACELLULAR VESICLES
IRON
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/282503

id CONICETDig_c2fbefe3987f4a202f5e756302548a00
oai_identifier_str oai:ri.conicet.gov.ar:11336/282503
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling The Intranasal Administration of Transferrin‐Loaded Extracellular Vesicles Enhances RemyelinationMattera, Vanesa SoledadOLIGODENDROCYTESMYELINATIONEXTRACELLULAR VESICLESIRONhttps://purl.org/becyt/ford/1.6https://purl.org/becyt/ford/1Oligodendrocytes (OLs), the myelinating glial cells of the central nervous system (CNS), are impaired in demyelinating diseases such as multiple sclerosis (MS). OL loss is characterized by inflammation, immune cell activity, and a failure of remyelination due to oligodendrocyte dysfunction and death, ultimately leading to demyelination and axonal damage. Given their central role in maintaining CNS integrity, therapeutic strategies aimed at protecting or restoring OL function are essential. Moreover, the limited permeability of the blood–brain barrier to many therapeutic compounds remains a major challenge, highlighting the need for innovative delivery approaches. Among these, the intranasal (IN) route has emerged as a promising noninvasive strategy for targeting the CNS. Within this therapeutic framework, Transferrin (Tf), a glycoprotein involved in iron homeostasis, has been shown to promote both developmental myelination and remyelination by redistributing and delivering iron, an essential cofactor for OL maturation and oxidative metabolism. In parallel, extracellular vesicles (EVs) have gained increasing attention as mediators of intercellular communication and potential drug delivery vehicles to the brain, offering advantages such as minimal immunogenicity, efficient cellular uptake, and cargo protection from degradation. In this review, the potential of EVs as biological carriers of molecules to promote remyelination is discussed, with a particular focus on Tf delivered via the intranasal route, as well as the cellular mechanisms underlying this internalization.Fil: Mattera, Vanesa Soledad. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Química y Físico-Química Biológicas "Prof. Alejandro C. Paladini". Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Instituto de Química y Físico-Química Biológicas; ArgentinaWiley Blackwell Publishing, Inc2025-10info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/282503Mattera, Vanesa Soledad; The Intranasal Administration of Transferrin‐Loaded Extracellular Vesicles Enhances Remyelination; Wiley Blackwell Publishing, Inc; Journal of Neurochemistry; 169; 10; 10-2025; 1-60022-3042CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://onlinelibrary.wiley.com/doi/10.1111/jnc.70260info:eu-repo/semantics/altIdentifier/doi/10.1111/jnc.70260info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2026-03-11T12:55:11Zoai:ri.conicet.gov.ar:11336/282503instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982026-03-11 12:55:12.106CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv The Intranasal Administration of Transferrin‐Loaded Extracellular Vesicles Enhances Remyelination
title The Intranasal Administration of Transferrin‐Loaded Extracellular Vesicles Enhances Remyelination
spellingShingle The Intranasal Administration of Transferrin‐Loaded Extracellular Vesicles Enhances Remyelination
Mattera, Vanesa Soledad
OLIGODENDROCYTES
MYELINATION
EXTRACELLULAR VESICLES
IRON
title_short The Intranasal Administration of Transferrin‐Loaded Extracellular Vesicles Enhances Remyelination
title_full The Intranasal Administration of Transferrin‐Loaded Extracellular Vesicles Enhances Remyelination
title_fullStr The Intranasal Administration of Transferrin‐Loaded Extracellular Vesicles Enhances Remyelination
title_full_unstemmed The Intranasal Administration of Transferrin‐Loaded Extracellular Vesicles Enhances Remyelination
title_sort The Intranasal Administration of Transferrin‐Loaded Extracellular Vesicles Enhances Remyelination
dc.creator.none.fl_str_mv Mattera, Vanesa Soledad
author Mattera, Vanesa Soledad
author_facet Mattera, Vanesa Soledad
author_role author
dc.subject.none.fl_str_mv OLIGODENDROCYTES
MYELINATION
EXTRACELLULAR VESICLES
IRON
topic OLIGODENDROCYTES
MYELINATION
EXTRACELLULAR VESICLES
IRON
purl_subject.fl_str_mv https://purl.org/becyt/ford/1.6
https://purl.org/becyt/ford/1
dc.description.none.fl_txt_mv Oligodendrocytes (OLs), the myelinating glial cells of the central nervous system (CNS), are impaired in demyelinating diseases such as multiple sclerosis (MS). OL loss is characterized by inflammation, immune cell activity, and a failure of remyelination due to oligodendrocyte dysfunction and death, ultimately leading to demyelination and axonal damage. Given their central role in maintaining CNS integrity, therapeutic strategies aimed at protecting or restoring OL function are essential. Moreover, the limited permeability of the blood–brain barrier to many therapeutic compounds remains a major challenge, highlighting the need for innovative delivery approaches. Among these, the intranasal (IN) route has emerged as a promising noninvasive strategy for targeting the CNS. Within this therapeutic framework, Transferrin (Tf), a glycoprotein involved in iron homeostasis, has been shown to promote both developmental myelination and remyelination by redistributing and delivering iron, an essential cofactor for OL maturation and oxidative metabolism. In parallel, extracellular vesicles (EVs) have gained increasing attention as mediators of intercellular communication and potential drug delivery vehicles to the brain, offering advantages such as minimal immunogenicity, efficient cellular uptake, and cargo protection from degradation. In this review, the potential of EVs as biological carriers of molecules to promote remyelination is discussed, with a particular focus on Tf delivered via the intranasal route, as well as the cellular mechanisms underlying this internalization.
Fil: Mattera, Vanesa Soledad. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Química y Físico-Química Biológicas "Prof. Alejandro C. Paladini". Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Instituto de Química y Físico-Química Biológicas; Argentina
description Oligodendrocytes (OLs), the myelinating glial cells of the central nervous system (CNS), are impaired in demyelinating diseases such as multiple sclerosis (MS). OL loss is characterized by inflammation, immune cell activity, and a failure of remyelination due to oligodendrocyte dysfunction and death, ultimately leading to demyelination and axonal damage. Given their central role in maintaining CNS integrity, therapeutic strategies aimed at protecting or restoring OL function are essential. Moreover, the limited permeability of the blood–brain barrier to many therapeutic compounds remains a major challenge, highlighting the need for innovative delivery approaches. Among these, the intranasal (IN) route has emerged as a promising noninvasive strategy for targeting the CNS. Within this therapeutic framework, Transferrin (Tf), a glycoprotein involved in iron homeostasis, has been shown to promote both developmental myelination and remyelination by redistributing and delivering iron, an essential cofactor for OL maturation and oxidative metabolism. In parallel, extracellular vesicles (EVs) have gained increasing attention as mediators of intercellular communication and potential drug delivery vehicles to the brain, offering advantages such as minimal immunogenicity, efficient cellular uptake, and cargo protection from degradation. In this review, the potential of EVs as biological carriers of molecules to promote remyelination is discussed, with a particular focus on Tf delivered via the intranasal route, as well as the cellular mechanisms underlying this internalization.
publishDate 2025
dc.date.none.fl_str_mv 2025-10
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/282503
Mattera, Vanesa Soledad; The Intranasal Administration of Transferrin‐Loaded Extracellular Vesicles Enhances Remyelination; Wiley Blackwell Publishing, Inc; Journal of Neurochemistry; 169; 10; 10-2025; 1-6
0022-3042
CONICET Digital
CONICET
url http://hdl.handle.net/11336/282503
identifier_str_mv Mattera, Vanesa Soledad; The Intranasal Administration of Transferrin‐Loaded Extracellular Vesicles Enhances Remyelination; Wiley Blackwell Publishing, Inc; Journal of Neurochemistry; 169; 10; 10-2025; 1-6
0022-3042
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/url/https://onlinelibrary.wiley.com/doi/10.1111/jnc.70260
info:eu-repo/semantics/altIdentifier/doi/10.1111/jnc.70260
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Wiley Blackwell Publishing, Inc
publisher.none.fl_str_mv Wiley Blackwell Publishing, Inc
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1859460888505876480
score 12.977003